BlueLight Therapeutics
South San Francisco, US · 3 known investors
Find your way into BlueLight Therapeutics
Sign up to find every way you can get introduced to BlueLight Therapeutics
- Your email: who you already know at BlueLight Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BlueLight Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
BlueLight Therapeutics develops novel drug molecules using a proprietary structure-based discovery platform targeting high-value therapeutic targets in life sciences.
Founders & leadership
AG
Ariel G. NotcovichFounder & CEO
MG
Mark GallopCSO
MC
Mira ChaurushiyaCBO
AS
Anjanabha SahaVP, Discovery
Investors · 3
5AM Ventures✓ confirmed by BlueLight TherapeuticsSan Francisco · $100K – $4M
How we know: the company's own site · a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does BlueLight Therapeutics do?
- BlueLight Therapeutics develops novel drug molecules using a proprietary structure-based discovery platform targeting high-value therapeutic targets in life sciences.
- Who founded BlueLight Therapeutics?
- BlueLight Therapeutics was founded by Ariel G. Notcovich.
- Who are BlueLight Therapeutics's investors?
- BlueLight Therapeutics's investors include 5AM Ventures, Pfizer Ventures, Pfizer Venture Investments.
- Where is BlueLight Therapeutics headquartered?
- BlueLight Therapeutics is headquartered in South San Francisco, US.
